Concepedia

Publication | Open Access

Irbesartan Reduces the Albumin Excretion Rate in Microalbuminuric Type 2 Diabetic Patients Independently of Hypertension

DOIFull Paper Access

71

Citations

27

References

2002

Year

Ferdinando Carlo Sasso, Ornella Carbonara, Marcello Persico, Dario Iafusco, Teresa Salvatore, Rosanna D’Ambrosio, Roberto Torella, Domenico Cozzolino
Diabetes Care

Abstract

These results indicate the beneficial effects of irbesartan on AER in type 2 diabetic subjects, independently of its antihypertensive effects.

References

YearCitations

Page 1